130 related articles for article (PubMed ID: 19309363)
1. Epstein-Barr virus-encoded latent membrane protein 1 activates beta-catenin signaling in B lymphocytes.
Tomita M; Dewan MZ; Yamamoto N; Kikuchi A; Mori N
Cancer Sci; 2009 May; 100(5):807-12. PubMed ID: 19309363
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.
Morrison JA; Klingelhutz AJ; Raab-Traub N
J Virol; 2003 Nov; 77(22):12276-84. PubMed ID: 14581564
[TBL] [Abstract][Full Text] [Related]
3. Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.
Terrin L; Dal Col J; Rampazzo E; Zancai P; Pedrotti M; Ammirabile G; Bergamin S; Rizzo S; Dolcetti R; De Rossi A
J Virol; 2008 Oct; 82(20):10175-87. PubMed ID: 18684838
[TBL] [Abstract][Full Text] [Related]
4. Human T-cell leukemia virus type 1 tax dysregulates beta-catenin signaling.
Tomita M; Kikuchi A; Akiyama T; Tanaka Y; Mori N
J Virol; 2006 Nov; 80(21):10497-505. PubMed ID: 16920823
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.
Incrocci R; Barse L; Stone A; Vagvala S; Montesano M; Subramaniam V; Swanson-Mungerson M
Virology; 2017 Jan; 500():96-102. PubMed ID: 27792904
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus latent membrane protein-1 effects on junctional plakoglobin and induction of a cadherin switch.
Shair KH; Schnegg CI; Raab-Traub N
Cancer Res; 2009 Jul; 69(14):5734-42. PubMed ID: 19584275
[TBL] [Abstract][Full Text] [Related]
7. Unique signaling properties of CTAR1 in LMP1-mediated transformation.
Mainou BA; Everly DN; Raab-Traub N
J Virol; 2007 Sep; 81(18):9680-92. PubMed ID: 17626074
[TBL] [Abstract][Full Text] [Related]
8. Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription.
Mehl AM; Floettmann JE; Jones M; Brennan P; Rowe M
J Biol Chem; 2001 Jan; 276(2):984-92. PubMed ID: 11034993
[TBL] [Abstract][Full Text] [Related]
9. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
Price AM; Messinger JE; Luftig MA
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
[TBL] [Abstract][Full Text] [Related]
10. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE
PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949
[TBL] [Abstract][Full Text] [Related]
11. LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells.
Shin JY; Kim JO; Lee SK; Chae HS; Kang JH
BMC Cancer; 2010 Aug; 10():425. PubMed ID: 20704765
[TBL] [Abstract][Full Text] [Related]
12. Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells.
Vangamudi B; Zhu S; Soutto M; Belkhiri A; El-Rifai W
Mol Cancer; 2011 Mar; 10():32. PubMed ID: 21447180
[TBL] [Abstract][Full Text] [Related]
13. The Latent Membrane Protein 1 (LMP1).
Kieser A; Sterz KR
Curr Top Microbiol Immunol; 2015; 391():119-49. PubMed ID: 26428373
[TBL] [Abstract][Full Text] [Related]
14. The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells.
Pratt ZL; Zhang J; Sugden B
J Virol; 2012 Apr; 86(8):4380-93. PubMed ID: 22318153
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus associated modulation of Wnt pathway is not dependent on latent membrane protein-1.
Webb N; Connolly G; Tellam J; Yap AS; Khanna R
PLoS One; 2008 Sep; 3(9):e3254. PubMed ID: 18806872
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.
Lin KM; Lin SJ; Lin JH; Lin PY; Teng PL; Wu HE; Yeh TH; Wang YP; Chen MR; Tsai CH
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776277
[TBL] [Abstract][Full Text] [Related]
17. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL.
Kanemitsu N; Isobe Y; Masuda A; Momose S; Higashi M; Tamaru J; Sugimoto K; Komatsu N
Clin Cancer Res; 2012 Apr; 18(8):2164-72. PubMed ID: 22371452
[TBL] [Abstract][Full Text] [Related]
18. Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells.
Salamon D; Adori M; Ujvari D; Wu L; Kis LL; Madapura HS; Nagy N; Klein G; Klein E
J Virol; 2012 Apr; 86(8):4701-7. PubMed ID: 22345482
[TBL] [Abstract][Full Text] [Related]
19. Syk activation of phosphatidylinositol 3-kinase/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus+ (EBV+) B cell lymphomas.
Hatton O; Phillips LK; Vaysberg M; Hurwich J; Krams SM; Martinez OM
J Biol Chem; 2011 Oct; 286(43):37368-78. PubMed ID: 21908615
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
Portis T; Longnecker R
Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
